VICTOZA

Google image searchProduct monograph

Active ingredient

liraglutide, 6 MG/ML

DIN: 02351064

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: MULTIDOSE PEN-INJECTOR. 30DOSES(0.6MG)-15DOSES(1.2MG)-10DOSES(1.8MG). 1/2/3

Schedule: Prescription / Schedule D

Company: NOVO NORDISK CANADA INC

Date: 27-MAY-2010

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BJ — Glucagon-like peptide-1 (GLP-1) analogues (ATC, ATC/DDD)
• A10BJ02 — LIRAGLUTIDE (ATC/DDD)

Reference brand drug: Victoza, Saxenda

Pharmaceutical standard: MFR

External Links for Victoza

Search on Google

• Victoza side effects
• Victoza dosage
• liraglutide side effects
• liraglutide dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find victoza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.